FLC
LVACW

Fifth Lane Capital’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Fifth Lane Capital’s Portfolio LVACW Stock Details LVACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50,000
Closed -$29K – 410
2021
Q4 		$29K Buy
+50,000
New +$25.7K 0.02% 214

Other funds holding LVACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Fifth Lane Capital's LVACW Position: Q1 2022 in Review

Fifth Lane Capital sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q1 2022, closing a stake of 50,000 shares — an estimated $29K sold.

Fifth Lane Capital first reported a position in LVACW in Q4 2021 and held it in 1 quarter. The position peaked at $29K in Q4 2021. 29 funds tracked by Wall St. Rank hold LVACW as of Q1 2022.

  • Fifth Lane Capital reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q1 2022 after selling out during the quarter.
  • Fifth Lane Capital sold 50,000 LAVA Medtech Acquisition Corp. Warrants shares in Q1 2022, an estimated $29K.
  • Fifth Lane Capital first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2021 and held it in 1 quarter.
  • Fifth Lane Capital's LAVA Medtech Acquisition Corp. Warrants position peaked at $29K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q1 2022.

Based on Fifth Lane Capital's 13F filing for Q1 2022, filed 16 May 2022.